Powders Pharma raw materials Capecitabines CAS 154361-50-9 for Cancer Treatment

Product Description

Capecitabines

1. Basic information:

Product Name: Capecitabines
CAS: 154361-50-9
MF: C15H22FN3O6
MW: 359.35
Mol File: 154361-50-9.mol

2. Chemical Properties:

MP 110-121°C
storage temp. -20°C Freezer
CAS DataBase Reference 154361-50-9

3. Safety Information:

Hazard Codes T
Risk Statements 45-60-61-68
Safety Statements 53-22-36/37-45
Hazardous Substances Data 154361-50-9(Hazardous Substances Data)

4. Product Description:

Capecitabines, is a kind of fluorine pyrimidine carbamate deoxyuridine drug that can transform into 5 - FU in the body and inhibit cell division and disturb the synthesis of RNA and protein. Capecitabines applies to the further treatment of advanced primary or metastatic breast cancer that failed to respond to other chemotherapy regimens including anthracycline antibiotics. Its main usage is treating advanced primary or metastatic breast cancer, rectal cancer, colon cancer and stomach cancer.

5. Usage And Synthesis:

(1). Novel Oral Fluoride Pyrimidine Drugs

As a novel oral fluoride pyrimidine drug, Capecitabines interacts with tumor cells by transforming to 5-FU in a three-step polymerase chain reaction. Its curative effect obviously correlates with the expression level of TP and DPD enzymes of tumor tissues.


5. Application:

1. Noval oral fluoride pyrimidine drug.
2. Anticancer drug, mainly used in non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.